Biosector has been a leading supplier of vaccine adjuvants since 1939
For more than 75 years Biosector has been dedicated to produce and develop vaccine adjuvants suitable for use in both human and veterinary vaccines. This unique historical focus has formed the basis for a strong market position and brands such as Alhydrogel®, Adju-Phos® and Quil-A® are widely recognized in the vaccine industry.
Vaccine adjuvants are a highly heterogenous collection of compounds that share only one functional characteristic: that of being able to enhance immune responses.
It is the aim of Brenntag Biosector to offer high quality adjuvants, not just for today’s vaccines, but also for the vaccines of tomorrow. We share our adjuvant knowledge with vaccinologists to facilitate effective vaccine design.
We call it : The Adjuvant Platform
We are committed to optimizing our business by ensuring high quality and safe products, delivered on time. We ensure high and consistent quality by manufacturing according to good manufacturing practice (GMP) and in compliance with customer expectations and applicable regulatory requirements. We strive to continually improve our Quality Management System through established quality metrics.
Brenntag Biosector A/S
Warehouse & sales